High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma

By Engelhardt M.   Zeiser R.   Ihorst G.   Finke J.   Müller C.  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 1, 2007-01 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Five-year results of cyclic semi-high dose neoadjuvant chemotherapy supported by autologous peripheral blood stem-cell transplantation in patients with advanced ovarian cancer

By Ikeba Kazunori   Okubo Mitsuo   Takeda Satoru   Kinoshita Katsuyuki   Maeda Hiroo  

International Journal of Clinical Oncology, Vol. 9, Iss. 2, 2004-04 ,pp. : 113-119

Springer Publishing Company

Access to resources Recommend Favorite

High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors

By Pérez-Martínez Antonio   Lassaletta Alvaro   González-Vicent Marta   Sevilla Julián   Díaz Miguel   Madero Luis  

Journal of Neuro-Oncology, Vol. 71, Iss. 1, 2005-01 ,pp. : 33-38

Springer Publishing Company

Access to resources Recommend Favorite

Very High-dose Chemotherapy with Autologous Peripheral Stem Cell Support in Advanced Ovarian Cancer

By Benedetti-Panici P.   Greggi S.   Scambia G.   Salerno M.G.   Baiocchi G.   Laurelli G.   Menichella G.   Pierelli L.   Foddai M.L.   Serafini R.   Bizzi B.   Mancuso S.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 1987-1992

Elsevier

Access to resources Recommend Favorite

Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

By Schuster Michael  

Supportive Care in Cancer, Vol. 16, Iss. 5, 2008-05 ,pp. : 477-483

Springer Publishing Company

Access to resources Recommend Favorite